Targeting disialoganglioside GD2 with chimeric antigen receptor-redirected T cells in lung cancer

• Giovanni Fucà,
• Barbara Savoldo,
• Gianpietro Dotti,
• Hong Lee,
• Jared Weiss,
• Loïc Reppel,
• Ourania Tsahouridis,
• Jason Akulian,
• Ian J Davis,
• Chad V Pecot

Affiliations

Giovanni Fucà

Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA

Barbara Savoldo

Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA

Gianpietro Dotti

Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA

Hong Lee

Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA

Jared Weiss

Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA

Loïc Reppel

Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA

Ourania Tsahouridis

Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA

Jason Akulian

Division of Pulmonary and Critical Care, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA

Ian J Davis

Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA

Chad V Pecot

Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA